RE: AHSNs have delivered 11 national adoption and spread programmes and supported the rapid uptake of 28 NICE-approved products. These initiatives alone have benefited more than 2.3 million patients. AHSNs have also helped to leverage investment of more than £1.8bn for UK Plc in the same timeframe.28 May 2023 16:19
Rookie72...the company stated in the 31st March RNS that the 2m drawdown was specifically (although) not uniquely for the commercialisation of AIGL. So not speculation but based on what the company has publicly stated.